• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov7
Neumora Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3506 (forecast USD -0.3333)
04:00
Neumora Therapeutics released FY2025 9 Months Earnings on November 6, 2025 (EST), with actual revenue of USD 0 and EPS of USD -1.0979
04:00
Nov6
Neumora Announces Advances in Neuroscience Drug Development
12:24
Oct29
ARCH Venture Partners X, LLC Acquires Common Shares of Neumora Therapeutics Inc.
23:20
Analyst Suneja Reiterates Buy Recommendation on Neumora Therapeutics
11:41
Oct27
Suvannavejh and H.C. Wainwright Reaffirm Buy Rating and Price Target for Neumora Therapeutics Inc.
12:52

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -56.76 M, EPS -0.3506

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -52.73 M, EPS -0.3261

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -67.99 M, EPS -0.4211

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
GLTO
17.250
+248.48%
+12.300
MOVE
11.910
+149.69%
+7.140
COLAR
0.4299
+126.26%
+0.240
COGT
32.460
+119.03%
+17.640
HKIT
4.150
+89.50%
+1.960
SELX
1.050
+85.51%
+0.484
VCIG
1.770
+71.84%
+0.740
MSGY
1.460
+53.68%
+0.510
SWAG
3.060
+45.71%
+0.960
NVTX
47.420
+45.37%
+14.800
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy